Search results
Results From The WOW.Com Content Network
The payout ratio is still manageable at 75% of earnings. Analysts believe Pfizer could grow earnings per share by an average of 10% annually over the next three to five years, which makes sense if ...
Based on our focused execution and strong year-to-date results, we are raising our full year '24 revenue guidance by $1.5 billion and our adjusted diluted earnings per share by $0.30.
PFE earnings call for the period ending June 30, 2024. ... maintaining and growing our dividend over time. ... goals. 2024 is clearly a foundation year for Pfizer. Our achievements to date set the ...
The good news on this front, though, is that Pfizer is poised to improve its bottom line and make its dividend even safer. Sure, the big pharma company's earnings fell 11% year over year in Q2.
Pfizer's high dividend yield and robust pipeline could offer significant returns for patient investors. ... The stock's forward price-to-earnings (P/E) ratio of 9.5x 2026 projected earnings also ...
For premium support please call: 800-290-4726 more ways to reach us
With a lot of new drugs to sell, Pfizer expects adjusted earnings to reach a range between $2.15 and $2.35 per share this year, which is more than it needs to meet a dividend commitment currently ...
For premium support please call: 800-290-4726 more ways to reach us